| |
FOR IMMEDIATE RELEASE
SKYSCAPE AND THOMSON CENTERWATCH MAKE CLINICAL
TRIALS INFORMATION ACCESSIBLE TO PHYSICIANS AT THE POINT-OF-CARE
Medical Professionals Can Now Access Clinical
Trial Information on PDAs
HUDSON, MASS.—December 15, 2004—Although more than
75 percent of pharmaceutical companies conduct clinical trials
before getting FDA approval, useful trial information is not
reaching the medical professionals who need it most. Skyscape
today announced an agreement with Thomson CenterWatch to solve
this problem by giving physicians PDA access to relevant facts
on drugs in trials, patient eligibility and trial results.
The new Skyscape software, DrugTrials™ (Thomson CenterWatch
Pipeline Intelligence)
and DrugStudies™ (Thomson CenterWatch Clinical Trial Listings),
is based on clinical trial information from Thomson CenterWatch.
With a stylus tap, physicians can present patients with appropriate
treatment suggestions, uncover trial results on relevant drugs
and be more aware of local and national clinical trials.
“Unlike other services that just list barebones information
for trial recruitment, this new solution provides a comprehensive
resource physicians can use daily to provide better care for
patients,” said RJ Mathew, vice president of marketing
and business development for Skyscape.
For example, if an oncologist is looking for all available
treatment options for a patient with acute cancer—he can
check the status of drugs in the research pipeline as well as
determine if there are open clinical trials using the DrugStudies
database via Skyscape’s smARTlink™ technology.
The new Skyscape offerings include the following titles:
- DrugTrials™ (Thomson CenterWatch Pipeline Intelligence)
—When searching by medical condition, physicians can
identify potentially life-saving treatments and learn about
the safety and efficacy of treatments in active trials. The
searchable database covers nearly 2,500 U.S. and Canadian
drugs spanning phase I - IV, as well as post-marketing results.
- DrugStudies™ (Thomson CenterWatch Clinical Trial
Listings)—Users can search more than 14,000 industry-sponsored
clinical trials actively recruiting patients either by geographic
location or therapeutic area. This service is fully integrated
with other Skyscape titles so if a relevant clinical trial
is occurring for a similar drug, they can instantly find out
and provide patients all their options.
“Our surveys have shown that more than 70% of patients
are interested in information about clinical trials, but most
of those patients have little to no idea who conducts clinical
trials or where to find one,” said Dan McDonald, vice
president, Thomson CenterWatch. “With Skyscape, we are
bringing crucial clinical data to physicians that did not
previously have access or insight to these studies and will
now be able to share timely information with patients at the
point-of-care.”
Pricing and Availability
DrugTrials and DrugStudies are easy to purchase, install and
use on the handheld. Both are available online via a one-click
download from www.skyscape.com.
The DrugTrials suite, which includes DrugStudies, is available
for $79.95—a 75 percent discount over the Web-based version.
Alternatively, DrugStudies is available separately for $19.95.
In addition to the CenterWatch titles, Skyscape users can also
select from Skyscape’s ever-expanding portfolio of more
than 240 trusted medical references in 35 specialties.
About The Thomson Corporation and CenterWatch
The Thomson Corporation (www.thomson.com),
with 2003 revenues from continuing operations of $7.6 billion,
is a global leader in providing integrated information solutions
to business and professional customers in the fields of healthcare
and scientific research, law, tax, accounting, financial services,
higher education, reference information, corporate training
and testing and assessment. Its healthcare solutions include
CenterWatch (www.centerwatch.com),
a leader in the clinical trials industry. With a specific focus
on the clinical trials industry, CenterWatch is a Boston-based
publishing and information services company that provides business
journalism, reference databases, accredited training manuals,
original research and analysis, and market intelligence services
to assist organizations in managing and implementing clinical
research strategies and operational initiatives. The Thomson
Corporation's common shares are listed on the Toronto and New
York stock exchanges (TSX: TOC;
NYSE: TOC)
About Skyscape
Skyscape is the leading provider of interactive, intelligent
mobile solutions that improve the quality and efficiency of
patient care and help reduce medical errors. Skyscape provides
more than 240 of medicine’s most trusted and reputable
medical references, from more than 30 major medical publishers,
for over 35 medical specialties, all integrated via its patented
smARTlink technology. Skyscape’s Constellation suites
are all-in-one decision support solutions customized for individual
specialties and include critical information on drugs, diseases,
interactions, lab information, treatment options and guidelines.
Skyscape has the largest installed base of paying customers
in the industry, including hospitals, medical schools and individual
practitioners at hundreds of leading institutions. Skyscape’s
solutions are available on multiple platforms, including Palm
OS®, Windows® CE and Pocket PC. For more information
about Skyscape, visit www.skyscape.com.
###
Skyscape and smARTlink are registered trademarks. All trademarks
are the property of their respective owners.
|
